Differential effects of beta-adrenergic receptor blockade in basolateral amygdala or insular cortex on incidental and associative taste learning.
The importance of central beta-adrenergic system has been essentially investigated in aversive/emotional learning tasks. However, recent data suggest that the beta-adrenergic system is also required for incidental taste learning. In the present study we evaluated in rats whether beta-adrenergic receptor activity is required for taste habituation, an incidental taste learning, and also for conditioned taste aversion (CTA) learning, an associative learning. To address this issue, a low dose of the beta-adrenergic antagonist propranolol was infused before learning in either the basolateral amygdala (BLA) or the insular cortex (IC), two forebrain areas reported to play a key role in taste memory formation. Incidental taste learning was assessed using a single presentation of the sweet taste saccharin 0.1%, which is sufficient to increase saccharin consumption (relative to water baseline) during a second presentation. CTA was assessed by pairing the first saccharin 0.1% presentation with a delayed gastric malaise, thus causing a decrease in saccharin consumption (relative to water baseline) during a second presentation. Propranolol infusion in BLA (1microg/0.2microl) or IC (2.5microg/0.5microl) before the first taste exposure impaired incidental taste learning but did not affect CTA. These results highlight the important role played by the beta-adrenergic receptor activation in cortical and amygdaloid structures during taste learning. Moreover, they are the first to suggest that incidental learning is more sensitive to blockade of noradrenergic system than associative learning.
Miranda
Maria Isabel
MI
Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, AP 1-1141, 76001 Querétaro, QRO, Mexico.
Rodríguez-García
Gabriela
G
Reyes-López
Julian V
JV
Ferry
Barbara
B
Ferreira
Guillaume
G
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000679:Amygdala / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D001245:Association Learning / Q000187:drug effects* / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology; D006185:Habituation, Psychophysiologic / Q000187:drug effects / Q000502:physiology; D008297:Male; D008845:Microinjections; D009638:Norepinephrine / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D013649:Taste
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D009638:Norepinephrine